Ulisse Biomed Spa
MIL:UBM
Ulisse Biomed Spa
Other Non-Cash Items
Ulisse Biomed Spa
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Ulisse Biomed Spa
MIL:UBM
|
Other Non-Cash Items
€14.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Genenta Science SPA
NASDAQ:GNTA
|
Other Non-Cash Items
€815.6k
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Philogen SpA
MIL:PHIL
|
Other Non-Cash Items
-€2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
Ulisse Biomed Spa
Glance View
Ulisse BioMed SpA is an Italian healthcare biotech company. The company is headquartered in Udine, Udine. The company went IPO on 2021-08-06. The firm focuses on creating new and transformative diagntostic platforms and products. The company creates diagnostic systems that can reach people directly and help increasing the frequency of health monitoring. Its platforms include Sagitta, NanoHybrid and Aptavir. Sagitta is a molecular diagnostics technology platform, capable of detecting and characterizing nucleic acids of viral, bacterial and eukaryotic origin. Sagitta is used to develop assays for Respiratory Viral Panel, Sexually Transmitted Diseases, Infectious Diseases and Oncology. NanoHybrid can be implemented not only to develop diagnostic solutions but also in the field of theranostics: the integration of a diagnostic method with a specific therapeutic intervention aimed at maximizing the effectiveness of the drug, as well as vaccine/immunoterapies monitoring. Aptavir is a platform for the identification and production of antiviral molecules.
See Also
What is Ulisse Biomed Spa's Other Non-Cash Items?
Other Non-Cash Items
14.5k
EUR
Based on the financial report for Dec 31, 2023, Ulisse Biomed Spa's Other Non-Cash Items amounts to 14.5k EUR.